Dexmetomedine for Post Operative Delirium in Elderly Patients Undergoing Elective Total Knee Replacement Under Spinal Anesthesia
NCT ID: NCT05707741
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2023-06-01
2024-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine Dosage for Postoperative Delirium and Cognitive Function in Elderly TKA Patients
NCT06614881
Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium
NCT05341154
Dexmedetomidine vs Propofol Sedation Reduces Postoperative Delirium in Patients Receiving Hip Arthroplasty.
NCT02793986
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
NCT00460473
Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.
NCT06366412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
normal saline infusion rate 0.4uq/kg /hour
dexmetomedine infusion
50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,
Dexmetomedine infusion
50 ml mixture of saline 48 ml and dexmedetomidine 200 μg
Group B
dexmetomedine 0.2 µg/kg/hr
dexmetomedine infusion
50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,
Dexmetomedine infusion
50 ml mixture of saline 48 ml and dexmedetomidine 200 μg
Group C
dexmetomedine 0.4 µg/kg/hr
dexmetomedine infusion
50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,
Dexmetomedine infusion
50 ml mixture of saline 48 ml and dexmedetomidine 200 μg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dexmetomedine infusion
50 ml mixture of saline 49 ml and dexmedetomidine 100 μg,
Dexmetomedine infusion
50 ml mixture of saline 48 ml and dexmedetomidine 200 μg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 65to 75 years old,
* Elective total knee arthroplasty under spinal anaesthesia.
Exclusion Criteria
* Allergy to any of the drugs used in the study
* Renal insufficiency
* Liver failure-Neurological abnormalities -patients with hearing and visual impairment
65 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rabab Mohammad habeeb
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
rabab M habeeb, Dr
Role: PRINCIPAL_INVESTIGATOR
Menoufia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Menoufia University
Menoufia, Menoufia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1/2023,ANET2-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.